Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
thyroid, desiccated (Oliva Therapeutics)
- Development stage
- Unknown
- Lead developer
- Oliva Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Amerithroid is a naturally derived desiccated thyroid extract (DTE) developed by Oliva Therapeutics and manufactured by Jerome Stevens Pharmaceuticals. Sourced from porcine thyroid glands, it provides a standardized combination of both levothyroxine (T4) and liothyronine (T3) thyroid hormones. Amerithroid is indicated as a replacement or supplemental therapy for patients with hypothyroidism of any etiology (except transient hypothyroidism during recovery from subacute thyroiditis). It is also used for pituitary thyroid-stimulating hormone (TSH) suppression in the treatment or prevention of euthyroid goiters (including thyroid nodules, subacute or chronic lymphocytic thyroiditis, and multinodular goiter) and in the management of thyroid cancer.
- Brand names
- AdthyzaAmerithroidArmour ThyroidEvexithroidNature-ThroidNiva ThyroidNP ThyroidRenThyroidWesthroid
- Other names
- desiccated thyroiddesiccated thyroid extractnatural desiccated thyroidporcine thyroidthyroid desiccatedthyroid extractthyroid, desiccated
02
Targets
THRB (Thyroid hormone receptor beta)THRA (Thyroid hormone receptor alpha)
Beyond the preview
Go deeper on thyroid, desiccated (Oliva Therapeutics).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on thyroid, desiccated (Oliva Therapeutics).